CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $213,000 | -88.2% | 16,609 | -93.6% | 0.18% | -87.7% |
| Q2 2022 | $1,806,000 | -15.6% | 257,621 | -0.2% | 1.43% | -4.3% |
| Q1 2022 | $2,139,000 | +20.8% | 258,073 | -1.3% | 1.50% | +6.9% |
| Q4 2021 | $1,770,000 | +24.9% | 261,403 | -2.3% | 1.40% | +20.3% |
| Q3 2021 | $1,417,000 | -3.9% | 267,437 | +4.2% | 1.16% | -7.7% |
| Q2 2021 | $1,475,000 | +25.3% | 256,566 | +0.5% | 1.26% | +16.7% |
| Q1 2021 | $1,177,000 | +65.1% | 255,266 | +19.6% | 1.08% | +48.4% |
| Q4 2020 | $713,000 | – | 213,432 | – | 0.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |